These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9240551)

  • 1. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
    Lassau N; Leclère J; Auperin A; Bourhis JH; Hartmann O; Valteau-Couanet D; Benhamou E; Bosq J; Ibrahim A; Girinski T; Pico JL; Roche A
    Radiology; 1997 Aug; 204(2):545-52. PubMed ID: 9240551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease.
    Lassau N; Auperin A; Leclere J; Bennaceur A; Valteau-Couanet D; Hartmann O
    Transplantation; 2002 Jul; 74(1):60-6. PubMed ID: 12134100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
    Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
    Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings.
    McCarville MB; Hoffer FA; Howard SC; Goloubeva O; Kauffman WM
    Pediatr Radiol; 2001 Feb; 31(2):102-5. PubMed ID: 11214676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment.
    Sonneveld P; Laméris JS; Cornelissen J; Ogilvie A; Löwenberg B
    Bone Marrow Transplant; 1998 Apr; 21(7):731-4. PubMed ID: 9578316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
    Qin CJ; Liu LJ; Zhang ZM; Luo L; Lai YR; Li QC
    Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):483-486. PubMed ID: 29996265
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive disease.
    Wingard JR; Niehaus CS; Peterson DE; Jones RJ; Piantadosi S; Levin LS; Saral R; Santos GW
    Oral Surg Oral Med Oral Pathol; 1991 Oct; 72(4):419-24. PubMed ID: 1923439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
    Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation.
    Erturk SM; Mortelé KJ; Binkert CA; Glickman JN; Oliva MR; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2006 Jun; 186(6):1497-501. PubMed ID: 16714636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT).
    Chung H; Im SA; Kim SK
    Pediatr Hematol Oncol; 2020 May; 37(4):275-287. PubMed ID: 32131664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear wave elastography and dispersion imaging for hepatic veno-occlusive disease prediction after pediatric hematopoietic stem cell transplantation: a feasibility study.
    Lee SB; Lee S; Cho YJ; Choi YH; Cheon JE; Hong KT; Choi JY; Kang HJ
    Pediatr Radiol; 2024 Jun; 54(7):1144-1155. PubMed ID: 38772925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation.
    Hashiguchi M; Okamura T; Yoshimoto K; Ono N; Imamura R; Yakushiji K; Ogata H; Seki R; Otsubo K; Oku E; Kuroiwa M; Higuchi M; Kato K; Taniguchi S; Gondo H; Shibuya T; Nagafuji K; Harada M; Sata M
    Bone Marrow Transplant; 2005 Dec; 36(12):1071-5. PubMed ID: 16247437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography.
    Herbetko J; Grigg AP; Buckley AR; Phillips GL
    AJR Am J Roentgenol; 1992 May; 158(5):1001-5. PubMed ID: 1566656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.
    Méresse V; Hartmann O; Vassal G; Benhamou E; Valteau-Couanet D; Brugieres L; Lemerle J
    Bone Marrow Transplant; 1992 Aug; 10(2):135-41. PubMed ID: 1525602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pretreatment regimen on mice liver injury in hematopoietic stem cell transplantation].
    Jia L; Yan ZL; Xu SJ; Xu KL; Zeng LY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):803-6. PubMed ID: 21302445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic findings in bone marrow transplant patients with symptomatic hepatic venoocclusive disease.
    Sharafuddin MJ; Foshager MC; Steinbuch M; Weisdorf DJ; Hunter DW
    J Ultrasound Med; 1997 Sep; 16(9):575-86. PubMed ID: 9321776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.
    Chen S; Osborn JD; Chen X; Boyer MW; McDonald GB; Hildebrandt GC
    Int J Hematol; 2015 Dec; 102(6):729-31. PubMed ID: 26497867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
    Park JE; Choi YH; Cheon JE; Kim WS; Kim IO; Ryu YJ; Kim YJ; Hong CR; Kang HJ
    Eur Radiol; 2018 Jun; 28(6):2291-2298. PubMed ID: 29294155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
    Kalayoglu-Besisik S; Yenerel MN; Caliskan Y; Ozturk S; Besisik F; Sargin D
    Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.